Suchergebnisse - "Verbinnen, Thierry"

PubPharm (5)

1

In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Verbinnen, T. | Fevery, B. | Vijgen, L. | +3

2

Efficacy of re-treatment with TMC435 as combination therapy in hepatitis C virus-infected patients following TMC435 monotherapy

enthalten in: Gastroenterology | 2012

von Lenz, O. | de Bruijne, J. | Vijgen, L. | +10

3

Replication capacity of minority variants in viral populations can affect the assessment of resistance in HCV chimeric replicon phenotyping assays

enthalten in: The Journal of antimicrobial chemotherapy | 2012

von Verbinnen, T. | Jacobs, T. | Vijgen, L. | +4

4

Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencing

enthalten in: Journal of virology | 2010

von Verbinnen, T. | Van Marck, H. | Vandenbroucke, I. | +7

5

In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435

enthalten in: Antimicrobial agents and chemotherapy | 2010

von Lenz, O. | Verbinnen, T. | Lin, T. | +16

1
[1]